ArticleMaterials today. Bio2024

Tumor microenvironment responsive nano-platform for overcoming sorafenib resistance of hepatocellular carcinoma.

Wenjing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.